Trials / Completed
CompletedNCT02094963
Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
A Randomized, Open-label, Parallel Group, Multicenter Phase IV Study to Assess Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management:TICAKOREA Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 800 (actual)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess safety and efficacy of Ticagrelor versus Clopidogrel in Asian/KOREAn patients with acute coronary syndromes intended for invasive management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ticagrelor | 180mg loading and 90mg bid |
| DRUG | Clopidogrel | 600mg loading and 75mg qd |
Timeline
- Start date
- 2014-07-05
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
- First posted
- 2014-03-24
- Last updated
- 2018-11-30
Locations
10 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02094963. Inclusion in this directory is not an endorsement.